Ibu and Hyporesponsive to stimuli - a phase IV clinical study of FDA data

Summary:

Hyporesponsive to stimuli is reported as a side effect among people who take Ibu (ibuprofen), especially for people who are male, 40-49 old, also take Fluoxetine, and have Gastrointestinal disorder.

The phase IV clinical study analyzes which people have Hyporesponsive to stimuli when taking Ibu. It is created by eHealthMe based on reports of 240,078 people who have side effects when taking Ibu from the FDA, and is updated regularly.

What is Ibu?

Ibu has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 246,531 Ibu users. Check the latest studies of Ibu.

What is Hyporesponsive to stimuli?

Hyporesponsive to stimuli (abnormally low degree of responsiveness on an agent, action, or condition) is found to be associated with 124 drugs and 228 conditions by eHealthMe. Check the latest studies of Hyporesponsive to stimuli.

On Jul, 18, 2026

240,078 people reported to have side effects when taking Ibu.
Among them, 21 people (0.01%) have Hyporesponsive to stimuli.

Could Ibu cause Hyporesponsive to stimuli?

Among these 21 people:

What is the gender of people who have Hyporesponsive to stimuli when taking Ibu? *

female: 19.05 %
male: 80.95 %

What is the age of people who have Hyporesponsive to stimuli when taking Ibu? *

What are other drugs people take besides Ibu? *

What are other side effects people have besides Hyporesponsive to stimuli? *

Overdose: 17 people, 80.95%
Hypotension (abnormally low blood pressure): 6 people, 28.57%
Fatigue (feeling of tiredness): 4 people, 19.05%
Blood Creatinine Increased: 4 people, 19.05%
Blood Urea Increased: 3 people, 14.29%
Dehydration (dryness resulting from the removal of water): 3 people, 14.29%
Depressed Level Of Consciousness: 3 people, 14.29%
Depression: 2 people, 9.52%
Confusional State: 2 people, 9.52%
Oxygen Saturation Decreased: 2 people, 9.52%

What are the existing conditions these people have? *

Tremor (trembling or shaking movements in one or more parts of your body): 1 person, 4.76%
Stress And Anxiety: 1 person, 4.76%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 4.76%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 4.76%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 4.76%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 4.76%
Memory Loss: 1 person, 4.76%
Intentional Self-Injury: 1 person, 4.76%
High Blood Cholesterol: 1 person, 4.76%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Ibu and have Hyporesponsive to stimuli?

- Check whether Hyporesponsive to stimuli is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ibu:

Ibu (246,531 reports)

Browse all side effects of Ibu:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyporesponsive to stimuli:

Hyporesponsive to stimuli (124 drugs)

Browse all the conditions that are associated with Hyporesponsive to stimuli:

Hyporesponsive to stimuli (228 conditions)

Related publications that referenced our studies

Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .
Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on ibuprofen (the active ingredients of Ibu) and Ibu (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.